GE HealthCare Technologies Inc.

Equities

GEHC

US36266G1076

Market Closed - Nasdaq Other stock markets 16:00:00 2026-03-12 EDT			5-day change	1st Jan Change
70.33 ^USD	-3.19%		-8.79%	-14.25%

03-11	Citigroup Adjusts PT on GE Healthcare Technologies to $84 From $88, Maintains Neutral Rating	MT
03-10	GE HealthCare Technologies Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-10-2026 08:00 AM

Transcript : GE HealthCare Technologies Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 09

Published on 09/09/2025 at 11:37 am EDT - Modified on 10/21/2025 at 09:08 am EDT

S&P Capital IQ

Presenter Speech
Patrick Wood (Analysts)

Hello, everyone. Thank you so much for joining. It's Patrick from U.S. Medtech Team. Firstly, disclaimers. So morganstanley.com/research disclosures, which is a

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about GE HealthCare Technologies Inc.

03-11	Citigroup Adjusts PT on GE Healthcare Technologies to $84 From $88, Maintains Neutral Rating	MT
03-10	GE HealthCare Technologies Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-10-2026 08:00 AM
03-09	GE Healthcare Announces U.S. FDA 510(K) Clearance for View, A Next-Generation Diagnostic Viewer Enabling Anywhere-Access to Radiologists	CI
03-09	GE Healthcare Says It Received FDA 510(k) Clearance for Imaging Software	MT
03-05	GE HealthCare Showcases AI-Powered And Cloud-First Healthcare Solutions At HIMSS 2026	CI
03-04	Argus Adjusts Price Target on GE Healthcare Technologies to $95 From $90, Maintains Buy Rating	MT
02-27	GE HealthCare enters 364-day revolving credit agreement	RE
02-27	GE Healthcare Technologies Inc. Announces Entry into New 364-Day Revolving Credit Agreement Replacing Prior Facility	CI
02-26	GE HealthCare Technologies Inc. Presents at Citi?s 2026 Unplugged MedTech and Life Sciences Access Day, Feb-26-2026 09:30 AM
02-25	Gentuity LLC Announces Advanced Intravascular Imaging Solutions to Become Available Through GE HealthCare in the United States	CI
02-24	Bravo Multinational Incorporated Announces Board Changes, Effective February 19, 2026	CI
02-19	GE HealthCare Achieves MRI Portfolio Milestone with FDA Clearances for Next-Generation SIGNA MRI Technology Designed to Enhance Precision Imaging and Clinical Efficiency	CI
02-19	GE HealthCare Says 510(k) Clearance Obtained for Three MRI Systems From US FDA	MT
02-17	GE Healthcare Technologies Inc. Builds on Barda Collaboration with Approximately $35 Million Expansion to Advance Artificial Intelligence-Powered Ultrasound for Trauma Care and Emergency Preparedness	CI
02-13	GE Healthcare Technologies Inc. Declares Cash Dividend for the First Quarter of 2026, Payable on May 15, 2026	CI